Balance Sheet Data
KalVista Pharmaceuticals, Inc. (KALV)
$9.515
-0.41 (-4.08%)
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Actual | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected | 2028 Projected |
| Total Cash | 100.81 | 67.71 | 248.93 | 166.20 | 149.38 | 82.67 | 65.05 | 51.19 | 40.28 | 31.70 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 11.31 | 16.53 | 10.42 | 14.10 | 16.57 | 7.85 | 6.17 | 4.86 | 3.82 | 3.01 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | 2.71 | 2.13 | 1.68 | 1.32 | 1.04 | 0.82 | 0.64 |
| Inventories (%) | ||||||||||
| Accounts Payable | 2.86 | 1.68 | 1.98 | 3.64 | 4.82 | 1.78 | 1.40 | 1.10 | 0.87 | 0.68 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -1.08 | -0.22 | -0.08 | -0.93 | -1.20 | -0.42 | -0.33 | -0.26 | -0.20 | -0.16 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.